AUG 10, 2026 · PHASE 1 TRIAL
A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight
ClinicalTrials.gov
Phase 1 safety and tolerability study of a novel agent in a focused population; no results posted in this registry record.
Reported
Planned enrollment30
Study phasePhase 1
Safety follow-up duration26 weeks